EBS » Topics » Selling, General and Administrative

This excerpt taken from the EBS 8-K filed Aug 6, 2009.

Selling, General and Administrative

 

2

 

 


 

 

 

For 2Q 2009, selling, general and administrative expenses were $19.4 million, an increase of $4.3 million, or 29 percent, from $15.0 million in 2Q 2008. This increase primarily reflects a $3.8 million non-cash impairment charge associated with the Company’s Frederick, Maryland facilities and an increase of $0.8 million in additional personnel and increased professional services to support growth of the business, partially offset by decreased expenses of $0.3 million in sales and marketing expenses.

 

For the six month period of 2009, selling, general and administrative expenses increased by $8.3 million, or 30 percent, to $35.3 million from $27.1 million for the comparable period of 2008. This increase primarily reflects an increase of approximately $3.5 million resulting from the addition of personnel and increased professional services for the Company’s headquarters organization, a $3.8 million non-cash impairment charge associated with the Company’s Frederick, Maryland facilities and a $1.4 million non-cash charge associated with acquisitions that were in progress but not completed as of December 31, 2008, partially offset by a decrease of $0.4 million in sales and marketing expenses.

 

This excerpt taken from the EBS 8-K filed May 8, 2009.

Selling, General and Administrative

For 1Q 2009, selling, general and administrative expenses were $16.0 million, an increase of $3.9 million, or 32 percent, from $12.1 million in 1Q 2008. SG&A expenses for 1Q 2009 reflect an increase of approximately $2.6 million resulting from the addition of personnel and increased professional services for the headquarters and staff organization to support the overall growth of the company’s business, and a $1.4 million charge for previously capitalized costs associated with the proposed Protein Sciences transaction, which we terminated in January 2009.

 

This excerpt taken from the EBS 8-K filed Mar 11, 2009.

Selling, General and Administrative

For 2008, selling, general and administrative expenses were $55.1 million, a decrease of $479,000, or 1 percent, from $55.6 million in 2007. The decrease was driven by $2.1 million representing reimbursement from the company’s insurance company and an invoice to the U.S. Department of Defense for legal fees associated with now completed product liability litigation, partially offset by an increase of approximately $1.8 million in our headquarters and staff organization to support the overall growth of our business.

 

This excerpt taken from the EBS 8-K filed Nov 10, 2008.

Selling, General and Administrative

For the third quarter of 2008, selling, general and administrative expenses decreased by $0.9 million, or 6 percent, to $14.1 million from $15.0 million for the comparable period of 2007. This decrease was primarily driven by lower costs in our headquarters and staff organization and primarily reflects a decrease of approximately $1.0 million resulting from decreased professional services for our headquarters organization, offset by an increase of $0.1 million in sales and marketing expenses related to the growth of our staff and an increase in our sales and marketing activities.

 

For the nine month period of 2008, selling, general and administrative expenses increased by $2.3 million, or 6 percent, to $41.2 million from $38.9 million for the comparable period of 2007. This increase was primarily driven by an increase in our headquarters and staff organization to support the overall growth of our business, and primarily reflects an increase of approximately $1.8 million resulting from the addition of personnel and increased legal and other professional services for our headquarters organization and an increase of $0.5 million in sales and marketing expenses related to the growth of our staff and an increase in our sales and marketing activities.

 

This excerpt taken from the EBS 8-K filed Aug 8, 2008.

Selling, General and Administrative

For the second quarter of 2008, selling, general and administrative expenses increased by $2.4 million, or 19 percent, to $15.0 million from $12.7 million for the comparable period of 2007. This increase is primarily attributable to an increase of approximately $2.1 million resulting from the addition of personnel and increased legal and other professional services related to the company’s headquarters and staff organization to support operations as a public company and the overall growth of the business, and an increase of $0.2 million in sales and marketing expenses related to the growth of staff and an increase in selling and marketing activities.

 

For the six month period of 2008, selling, general and administrative expenses increased by $3.2 million, or 14 percent, to $27.1 million from $23.9 million for the comparable period of 2007. This increase is primarily attributable to an increase of approximately $2.8 million resulting from the addition of personnel and increased legal and other professional services related to the company’s headquarters and staff organization to support operations as a public company and the overall growth of the business, and an increase of $0.4 million in sales and marketing expenses related to the growth of staff and an increase in selling and marketing activities.

 

This excerpt taken from the EBS 8-K filed May 7, 2008.

Selling, General and Administrative

For the first quarter of 2008, selling, general and administrative expenses increased by $0.9 million, or 8 percent, to $12.1 million from $11.2 million for the comparable period of 2007. This increase is primarily attributable to an increase of approximately $0.7 million resulting from the addition of personnel and increased legal and other professional services related to the company’s headquarters and staff organization to support operations as a public company and an increase of $0.2 million in sales and marketing expenses related to the growth of staff and an increase in selling and marketing activities.

 

This excerpt taken from the EBS 8-K filed Mar 11, 2008.

Selling, General and Administrative

For 2007, selling, general and administrative expenses increased by $11.0 million, or 25 percent, to $55.6 million from $44.6 million for 2006. This increase is primarily attributable to an increase of approximately $9.0 million resulting from the addition of personnel and increased legal and other professional services related to the company’s headquarters and staff organization to support operations as a public company and an increase of $2.0 million in sales and marketing expenses related to the growth of staff and an increase in our selling and marketing activities.

 

This excerpt taken from the EBS 8-K filed Nov 5, 2007.

Selling, General and Administrative

For the third quarter of 2007, selling, general and administrative expenses increased by $3.9 million to $15.0 million from $11.2 million for the comparable period in 2006. SG&A expenses related to the biodefense segment increased by $2.7 million, while SG&A expenses related to the commercial segment increased by $1.2 million.

 

For the nine month period of 2007, selling, general and administrative expenses increased by $8.5 million to $38.9 million from $30.4 million for the comparable period in 2006. SG&A expenses related to the biodefense segment increased by $5.5 million, while SG&A expenses related to the commercial segment increased by $3.1 million.

 

The increase for the third quarter and nine month period of 2007 in both segments was primarily attributable to an increase in general and administrative expenses resulting from the addition of personnel related to the company’s transition to a publicly traded company and increased legal and other professional services for the company’s headquarters organization.

 

This excerpt taken from the EBS 8-K filed Aug 7, 2007.

Selling, General and Administrative

For the second quarter of 2007, selling, general and administrative expenses increased by $3.2 million to $12.7 million from $9.4 million for the comparable period in 2006. SG&A expenses related to the biodefense segment increased by $2.4 million, while SG&A expenses related to the commercial segment increased by $858,000.

 

For the six month period of 2007, selling, general and administrative expenses increased by $4.7 million to $23.9 million from $19.2 million for the comparable period in 2006. SG&A expenses related to the biodefense segment increased by $2.8 million, while SG&A expenses related to the commercial segment increased by $1.9 million.

 

The increase for the second quarter and six month period of 2007 in both segments was primarily attributable to an increase in general and administrative expenses resulting from the addition of personnel related to the company’s transition to a publicly traded company and increased legal and other professional services for the company’s headquarters organization.

 

This excerpt taken from the EBS 8-K filed May 10, 2007.

Selling, General and Administrative

For the first quarter of 2007, selling, general and administrative expenses increased by $1.4 million to $11.2 million from $9.8 million for the comparable period in 2006. SG&A expenses related to the biodefense segment increased by $0.4 million to $8.9 million for the first quarter of 2007 from $8.4 million for the same period in 2006. SG&A expenses related to the commercial segment increased by $1.0 million to $2.3 million for the first quarter of 2007 from $1.3 million for the same period in 2006. The increase in both segments was primarily attributable to an increase in general and administrative expenses of approximately $1.2 million resulting from the addition of personnel related to the company’s transition to a publicly traded company and increased legal and other professional services for the company’s headquarters.

 

This excerpt taken from the EBS 8-K filed Mar 22, 2007.

Selling, General and Administrative

For 2006, selling, general and administrative expenses increased by $1.8 million, or 4 percent, to $44.6 million from $42.8 million for 2005. SG&A expenses related to the biodefense segment decreased by $0.5 million to $35.0 million for 2006 from $35.5 million for 2005. SG&A expenses related to the commercial segment increased by $2.3 million, or 32 percent, to $9.6 million for 2006 from $7.3 million for 2005. The increase in the commercial segment was primarily attributable to an increase in selling, general and administrative expenses of $1.0 million resulting from the addition of personnel and increased legal and other professional services for the company’s headquarters, and an increase of $0.9 million related to the addition of personnel for the company’s commercial development subsidiary in the UK.

 

 

2


 

 

 

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki